SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-000681
Filing Date
2023-01-04
Accepted
2023-01-04 08:30:15
Documents
14
Period of Report
2023-01-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea171147-8k_180lifesci.htm   iXBRL 8-K 33995
2 PRESS RELEASE DATED JANUARY 4, 2023 ea171147ex99-1_180lifesci.htm EX-99.1 14208
  Complete submission text file 0001213900-23-000681.txt   277444

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE atnf-20230104.xsd EX-101.SCH 3992
4 XBRL DEFINITION FILE atnf-20230104_def.xml EX-101.DEF 26629
5 XBRL LABEL FILE atnf-20230104_lab.xml EX-101.LAB 36680
6 XBRL PRESENTATION FILE atnf-20230104_pre.xml EX-101.PRE 25253
8 EXTRACTED XBRL INSTANCE DOCUMENT ea171147-8k_180lifesci_htm.xml XML 5676
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 23504434
SIC: 2834 Pharmaceutical Preparations